article thumbnail

How Pharmacists Can Use Artificial Intelligence To Advance Their Practice: Insights From ChatGPT

ID Stewardship

BCPS, BCIDP Article Posted 7 June 2023 With the exception of the questions in bold, this entire text was written by ChatGPT. We’ll dive into the many ways AI can assist pharmacists, from streamlining medication dispensing processes to enhancing patient education. Interview with: ChatGPT by OpenAI Interview by: Timothy P.

article thumbnail

Top Performing Drug – Trikafta/Kaftrio (May Edition)

PharmaShots

The report is concluded with an engaging SWOT analysis and edifying KOL reviews Active Ingredient: (elexacaftor, tezacaftor, and ivacaftor tablets, ivacaftor tablets) Dosage Forms & Strengths: Tablets: fixed-dose combination containing elexacaftor 100 mg, tezacaftor 50 mg, and ivacaftor 75 mg. In Apr 2023, Vertex announced the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. However, some may be concerned with this genetic information getting reported on insurance or to employers.

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

Many times, people have been able to eliminate their symptoms and reduce their dosages of medications. Luckily, even without insurance coverage, this medication is available in generic form and is very affordable, usually costing between $15 to $40 per month. It’s a process and a journey, but it’s definitely worth it.

article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

PharmaShots' analysis of Enbrel’s industry trials is depicted below: (Trials were taken on 6 Jun 2023). The chart depicts data till 8th Jun 2023). Plaque Psoriasis (Moderate to Severe): The drug is used for children aged 4≥yrs and adults Clinical Trials Analysis3 Currently, Enbrel is undergoing 541 trials, incl.